Halma plc HLMA

Halma (HLMAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HOPKINTON, MA / ACCESS Newswire / August 4, 2026 / Isto Biologics ("Isto"), a biologics company dedicated to advancing bone healing, today announced the acquisition of NovaBone Products LLC ("NovaBone"), a developer and manufacturer of synthetic bone ...

FTSE 100 up 1 point at 10,498 Oil prices hit 3-week high amid new US-Iran strikes Plus500, PageGroup, Oxford Nanopore post numbers 5.15pm: Investors cautious As investors eyed geopolitical developments, London stocks finished the day little changed, up 1 point at 10,498. The US’...

European stocks closed mostly lower on Tuesday as a sell-off in technology sector amid valuation concerns and worries about renewed tensions in the Middle East following attacks in the Strait of Hormuz on Monday. The sell-off in the sector comes following a near 7% plunge by shares of South Korean memory chipmaker Samsung Electronics amid concerns about spending and demand.

Halma PLC (HLMAF) surpasses financial targets with robust revenue and profit growth, while navigating currency headwinds and market volatility.

Halma (LON:HLMA) reported what management described as a “very strong” full-year 2026 performance, with broad-based organic growth across all three of its sectors and continued rapid expansion in its Photonics business. Marc opened the results presentation by saying the group had delivered its 23rd

Halma’s updated fair value is now set at £41.69, compared with the previous £40.33. This puts it broadly in line with price targets that cluster around £45.00, £41.50, 4,500 GBp and 4,150 GBp in recent analyst research. These targets, along with maintained Equal Weight and Neutral ratings, frame an active debate about how much of the revenue and margin story is already reflected in the stock. Read on to see how to interpret these shifting targets and keep track of the evolving analyst...

Salaera, a leading innovator and manufacturer of respiratory care, gas delivery and gas analysis technologies, has been named "Healthcare Company of the Year" by Halma plc at the Accelerate Halma 2026 Conference. The award recognizes outstanding performance among Halma's international group of life-saving technology companies spanning healthcare, safety and environmental markets.

Halma is back in focus after analysts lifted their core valuation markers, with one model fair value moving from £39.24 to £40.33 and JPMorgan raising its price target to 4,150 GBp from 4,000 GBp. That higher 4,150 GBp level, held alongside a Neutral rating, reflects a view that the shares can justify a slightly richer reference point without a clear shift in stance. Read on to see what is driving this updated narrative and how you can track it from here. Analyst Price Targets don't always...

Here is how Halma (HLMAF) and UniFirst (UNF) have performed compared to their sector so far this year.

Halma’s analyst narrative has been refreshed with a higher price target of £4,150, alongside an updated fair value estimate of £39.24. Research houses describe this shift as a blend of cautious and constructive views, where slightly stronger revenue assumptions sit next to modest margin tweaks and a still measured stance from JPMorgan. As you read on, you will see how these moving targets fit together and how to keep track of the story as it continues to evolve. Analyst Price Targets don't...

Halma’s updated analyst narrative now incorporates a £4.50 uplift in the price target, with the fair value estimate held at £38.69. Bullish analysts link this change to revised discount rate assumptions and what they see as stronger support from long term earnings expectations, while more cautious voices highlight how sensitive that target is to shifts in risk or growth inputs. As you read on, you will see how these differing views shape the evolving story around Halma and what it could mean...

Halma (HLMAF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.